The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.
 
Rin Ogiya
Honoraria - Novartis
 
Nobue Kumaki
No Relationships to Disclose
 
Giampaolo Bianchini
Honoraria - Eisai; Genomic Health; Roche Pharma AG
Consulting or Advisory Role - Genomic Health
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Takayuki Iwamoto
No Relationships to Disclose
 
Naoki Hayashi
Honoraria - Chugai Pharma; Eisai; Genomic Health; Novartis; Sanofi; Taiho Pharmaceutical; Takeda
 
Toshiya Tanaka
No Relationships to Disclose
 
Naoki Niikura
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Kyowa Hakko Kirin; Nihon Medi-Physics; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Chugai Pharma (Inst); Nihon Medi-Physics; Sanofi
 
Yutaka Tokuda
Honoraria - AstraZeneca; Chugai Pharma; Covidien; Daiichi Sankyo; Eisai; Fuji Pharma; GlaxoSmithKline; Kyowa Hakko Kirin; Meiji Seika Kaisha; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Kyowa Hakko Kirin; Novartis; Taiho Pharmaceutical; Takeda